Published in Infect Immun on November 01, 1973
The pulmonary clearance of Pasteurella hemolytica in calves infected with bovine parainfluenza-3 virus. Can J Comp Med (1976) 1.84
Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J Clin Invest (1976) 1.61
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry (2012) 1.41
Experimental bovine pneumonic pasteurellosis. I. Prevention of the disease. Can J Comp Med (1979) 1.35
Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. Can J Comp Med (1983) 1.14
Tracheal function during influenza infections. Infect Immun (1983) 0.93
Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica. Comp Med (2010) 0.93
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Non-dinitrophenyl-binding immunoglobulin that bears a dominant idiotype (Id460) associated with antidinitrophenyl antibody is specific for an antigen on Pasteurella pneumotropica. J Exp Med (1984) 0.91
Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (sendai) virus infections of mice. Antimicrob Agents Chemother (1976) 0.90
Exposure of calves to aerosols of parainfluenza-3 virus and Pasteurella haemolytica. Can J Comp Med (1983) 0.89
Bovine parainfluenza type 3 virus infection: ultrastructural aspects of viral pathogenesis in the bovine respiratory tract. Infect Immun (1975) 0.83
Stage of primary infection with lymphocytic choriomeningitis virus determines predisposition or resistance of mice to secondary bacterial infections. Med Microbiol Immunol (2006) 0.79
Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology (2016) 0.78
Enzyme-linked immunosorbent assay and immunoblot analysis of the immunoglobulin G response to whole-cell and lipooligosaccharide antigens of Pasteurella pneumotropica in laboratory mice with latent pasteurellosis. J Clin Microbiol (1989) 0.75
THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG. J Exp Med (1964) 5.16
The pathogenesis of Sendai virus infection in the mouse lung. J Med Microbiol (1968) 3.35
Interaction of influenza virus with leukocytes and its effect on phagocytosis. J Infect Dis (1969) 2.50
SYNERGISTIC ACTIVITY BETWEEN PR8 INFLUENZA VIRUS AND STAPHYLOCOCCUS AUREUS IN THE GUINEA PIG. Am J Hyg (1963) 2.19
The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung. J Clin Invest (1972) 2.19
Studies on the pathogenesis of influenza virus pneumonia in mice. J Pathol Bacteriol (1962) 2.16
Combined infections in mice with influenza virus and Diplococcus pneumoniae. Am J Hyg (1957) 1.98
Pulmonary clearance of infectious agents. Annu Rev Med (1968) 1.90
Synergism between respiratory viruses and bacteria. Yale J Biol Med (1968) 1.83
Pathogenesis of Sendai virus infection in mice. Am J Vet Res (1971) 1.74
A pneumotropic pasteurella of laboratory animals; bacteriological and serological characteristics of the organism. J Infect Dis (1950) 1.60
The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice. J Exp Med (1961) 1.57
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
Effect of intranasal reovirus infection on antibacterial activity of mouse lung. J Infect Dis (1969) 1.41
Role of Pasteurella pneumotropica and Mycoplasma pulmonis in murine pneumonia. J Bacteriol (1969) 1.37
Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza. J Infect Dis (1968) 1.36
Pasteurella pneumotropica: cultural and biochemical characteristics, and its association with disease in laboratory animals. Lab Anim Care (1965) 1.32
A pneumotropic pasteurella of laboratory animals; pathological and immunological studies with the organism. J Infect Dis (1950) 1.25
Alteration of the pathogenicity of Pasteurella pneumotropica for the murine lung caused by changes in pulmonary antibacterial activity. J Bacteriol (1967) 1.24
Natural history of Sendai virus infection in mice. Am J Epidemiol (1968) 1.22
A study of Pasteurella strains from animal sources. Antonie Van Leeuwenhoek (1963) 1.14
ENZOOTIC SENDAI VIRUS INFECTIONS IN MOUSE BREEDER COLONIES WITHIN THE UNITED STATES. Science (1964) 1.07
The use of chloramphenicol and foster mothers in the control of natural pasteurellosis in experimental mice. Aust J Exp Biol Med Sci (1953) 0.95
Viruses as precipitants of asthmatic attacks in children. JAMA (1974) 3.30
Defense mechanisms of the respiratory membrane. Am Rev Respir Dis (1977) 2.77
Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis (1976) 2.20
The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung. J Clin Invest (1972) 2.19
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings. J Pediatr (1974) 2.09
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy (1997) 1.76
Rapid detection and identification of respiratory viruses by direct immunofluorescence. Appl Microbiol (1970) 1.73
Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med (1997) 1.72
Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia. J Clin Invest (1973) 1.69
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J Clin Invest (1976) 1.61
Failure of inactivated influenza vaccine to protect an aged population. JAMA (1969) 1.56
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
Aerosol transmission of rhinovirus colds. J Infect Dis (1987) 1.45
Prolonged Salmonella contamination of a recreational lake by runoff waters. Appl Microbiol (1971) 1.44
Experimental infections of chimpanzees with human rhinovirus types 14 and 43. Proc Soc Exp Biol Med (1968) 1.43
Effect of sequential inoculations of Sendai virus and Pasteurella pneumotropica in mice. J Am Vet Med Assoc (1974) 1.39
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Diagnosis of pneumonia due to Pneumocystis by subsegmental pulmonary lavage via the fiberoptic bronchoscope. Chest (1978) 1.37
Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am Rev Respir Dis (1987) 1.32
In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis (1985) 1.27
Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med (1999) 1.25
Mechanisms of virus-induced bacterial superinfections of the lung. Clin Chest Med (1981) 1.24
A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J Infect Dis (1984) 1.22
Sources of variance in the measurement of intrapulmonary killing of bacteria. J Lab Clin Med (1976) 1.21
Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus. J Infect Dis (1979) 1.18
Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med (1995) 1.17
Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect Immun (1990) 1.17
Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms. Infect Immun (1976) 1.17
Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia. Infect Immun (1980) 1.14
Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Am Rev Respir Dis (1982) 1.09
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol (1996) 1.07
Alterations in lung macrophage immune receptor(s) activity associated with viral pneumonia. J Reticuloendothel Soc (1979) 1.06
Ultrastructural alterations in phagocytic functions of alveolar macrophages after parainfluenza virus infection. J Reticuloendothel Soc (1979) 1.06
Viral-bacterial interactions in pulmonary infection. Adv Vet Sci Comp Med (1982) 1.05
Enhancement by parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig. Am Rev Respir Dis (1987) 1.04
Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol (1984) 1.04
Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest (1981) 1.03
Epidemiology of infections with rhinovirus types 43 and 55 in a group of university of Wisconsin student families. Am J Epidemiol (1967) 1.03
Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J (1998) 1.02
Alveolitis induced by influenza virus. Am Rev Respir Dis (1983) 1.01
Suppression of pulmonary antibacterial activity following Sendai virus infection in mice: dependence on virus dose. Arch Virol (1975) 1.01
Regional defense mechanisms of the guinea pig lung. Am Rev Respir Dis (1973) 1.00
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Effects of pneumonia on intrapulmonary distribution of inhaled particles. Am Rev Respir Dis (1973) 0.98
Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects. J Allergy Clin Immunol (1978) 0.95
The role of respiratory viruses in asthma. Ciba Found Symp (1997) 0.94
Characterization of murine lung and peritoneal macrophages. J Reticuloendothel Soc (1980) 0.93
Pulmonary defense mechanisms and the interaction between viruses and bacteria in acute respiratory infections. Bull Eur Physiopathol Respir (1977) 0.93
Alterations in lung macrophage antimicrobial activity associated with viral pneumonia. Infect Immun (1979) 0.93
Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. J Infect Dis (1986) 0.93
Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis (1983) 0.93
Natural and experimental infections of nonhuman primates with respiratory viruses. Lab Anim Sci (1974) 0.92
Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J Infect Dis (1986) 0.92
Failure of naturally acquired rhinovirus infections to produce temporal immunity to heterologous serotypes. Infect Immun (1974) 0.90
Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes. J Infect Dis (1997) 0.90
Effect of hypersensitivity pneumonitis on the pulmonary defense mechanisms of guinea pig lungs. Infect Immun (1973) 0.90
Immune-enhanced phagocytic dysfunction in pulmonary macrophages infected with parainfluenza 1 (Sendai) virus. Am Rev Respir Dis (1981) 0.89
Effects of viral pneumonia on lung macrophage lysosomal enzymes. Infect Immun (1979) 0.89
Transmission and control of rhinovirus colds. Eur J Epidemiol (1987) 0.89
A genetic model for evaluation of susceptibility to ozone-induced inflammation. Am J Physiol (1990) 0.89
Alterations of pulmonary defense mechanisms by protein depletion diet. Infect Immun (1981) 0.89
Mechanisms of bacterial superinfections in viral pneumonias. Schweiz Med Wochenschr (1985) 0.88
Dynamics of viral growth, viral enzymatic activity, and antigenicity in murine lungs during the course of influenza pneumonia. J Med Virol (1984) 0.88
Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis (1992) 0.87
Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission. J Clin Microbiol (1975) 0.87
Genetic modeling of susceptibility to nitrogen dioxide-induced lung injury in mice. Am J Physiol (1997) 0.87
Effect of influenza A virus on leukocyte histamine release. J Allergy Clin Immunol (1983) 0.86
The participation of antiviral immune mechanisms in alveolar macrophage dysfunction during viral pneumonia. Bull Eur Physiopathol Respir (1983) 0.86
Protective effect of prophylactic penicillin on splenectomized mice exposed to an aerosolized suspension of type III Streptococcus pneumoniae. Blood (1979) 0.85
Haemophilus influenzae. Association with acute respiratory illness in adults. Arch Environ Health (1966) 0.84
Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone. Exp Lung Res (1991) 0.84
Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin Exp Allergy (2000) 0.84
Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: the role of prostanoids. Am J Physiol (1991) 0.83
Interstrain variation in murine susceptibility to inhaled acid-coated particles. Am J Physiol Lung Cell Mol Physiol (2000) 0.83
Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism. J Infect Dis (1996) 0.83
Reduced granulocyte response to isoproterenol, histamine, and prostaglandin E1 after in vitro incubation with Rhinovirus 16. Am Rev Respir Dis (1980) 0.83
Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung. Am Rev Respir Dis (1977) 0.82
Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung. Eur J Pharmacol (1983) 0.82
Characterization of the pulmonary inflammatory response to an anaerobic bacterial challenge. Am Rev Respir Dis (1986) 0.82
In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide. Am J Respir Cell Mol Biol (1991) 0.82
Effect of a rhinovirus-caused upper respiratory illness on pulmonary function test and exercise responses. Med Sci Sports Exerc (1997) 0.81
The pulmonary response to a bacteremic challenge. Am Rev Respir Dis (1975) 0.81
Short-duration exposure and the transmission of rhinoviral colds. J Infect Dis (1984) 0.81
Methylprednisolone impairs the bactericidal activity of alveolar macrophages. J Surg Res (1985) 0.81
Near disappearance of rhinovirus along a fomite transmission chain. J Infect Dis (1988) 0.81
Interactions between Sendai virus and bacterial pathogens in the murine lung: a reviews. Lab Anim Sci (1981) 0.80
Pulmonary inflammatory responses during viral pneumonia and secondary bacterial infection. Inflammation (1983) 0.80
Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation. Carcinogenesis (1992) 0.80
Rhinovirus infections in an isolated antarctic station. Transmission of the viruses and susceptibility of the population. Am J Epidemiol (1989) 0.80
Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med (1997) 0.80
Rhinovirus infections in hospitalized children. Provocative bacterial interrelationships. Arch Environ Health (1967) 0.79
Aminophylline-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis (1985) 0.79
Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice. Am Rev Respir Dis (1981) 0.79
Variations in pulmonary antibacterial defenses among experimental animals. Infect Immun (1975) 0.79
The role of viral infections in intrinsic asthma: activation of neutrophil inflammation. Agents Actions Suppl (1989) 0.78